JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schuit, F.
Right arrow Articles by Pipeleers, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schuit, F.
Right arrow Articles by Pipeleers, D.

J Biol Chem, Vol. 274, Issue 46, 32803-32809, November 12, 1999

Cellular Origin of Hexokinase in Pancreatic Islets

Frans Schuit, Karen Moens, Harry Heimberg, and Daniel Pipeleers

From the Diabetes Research Center, Vrije Universiteit Brussel, Brussels, B-1090 Belgium

Transgenic or tumoral pancreatic islet beta cells with enhanced expression of low Km hexokinases (HK) exhibit a leftward shift of the normal dose-response curve for glucose-induced insulin release. Furthermore, HK catalyzes roughly 50% of total glucose phosphorylation measured in extracts from freshly isolated rodent islets, suggesting that HK participates in the process of glucose sensing in beta cells. We previously observed that HK activity represents 20% of total glucose phosphorylation in purified rat beta cell preparations and that HK is not homogenously distributed over these cells. The present study provides several arguments for the idea that HK detected in freshly isolated rat islets or islet cell preparations originates mainly from contaminating exocrine cells. First, reverse transcriptase-polymerase chain reaction using isoform-specific primers allowed detection of hexokinase I and IV mRNA in rat beta cells, whereas the messenger levels encoding the hexokinase II and III isoforms were undetectably low. However, immunoblots indicated that hexokinase I protein was 10-fold more abundant in freshly isolated islets and flow-sorted exocrine cells than in purified rat beta cell preparations. Second, comparison of HK activity in the different pancreatic cell types resulted in 15-25-fold higher values in exocrine than in endocrine cells (acinar cells: 21 ± 3 pmol of glucose 6-phosphate formed/h/ng of DNA; duct cells: 30 ± 8 pmol/h/ng of DNA; islet beta cells: 1.2 ± 0.2 pmol/h/ng DNA; alpha cells: 0.9 ± 0.4 pmol/h/ng of DNA). Since freshly purified beta cell preparations contain 3 ± 1% exocrine cells, at least 50% of their HK activity can be accounted for by exocrine contamination. Third, after 5 days of culture of purified islet beta cells, both HK activity and the proportion of exocrine cells decreased by more than 1 order of magnitude, while the ratio of glucokinase over hexokinase activity increased more than 10-fold. Finally, preincubating the cells with 50 mmol/liter 2-deoxyglucose did not affect glucose stimulation of insulin biosynthesis and release. In conclusion, the observation that pancreatic exocrine cells are responsible for a major part of HK activity in islet cell preparations cautions against the use of HK measurements in islet extracts in the study of these enzymes in glucose sensing by pancreatic beta cells.


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.



This article has been cited by other articles:


Home page
J EndocrinolHome page
B Maiztegui, M I Borelli, M L Massa, H Del Zotto, and J J Gagliardino
Enhanced expression of hexokinase I in pancreatic islets induced by sucrose administration.
J. Endocrinol., May 1, 2006; 189(2): 311 - 317.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. A. Martens, Y. Cai, S. Hinke, G. Stange, M. Van de Casteele, and D. Pipeleers
Glucose Suppresses Superoxide Generation in Metabolically Responsive Pancreatic {beta} Cells
J. Biol. Chem., May 27, 2005; 280(21): 20389 - 20396.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
X.-J. Yang, L.-M. Kow, D. W. Pfaff, and C. V. Mobbs
Metabolic Pathways That Mediate Inhibition of Hypothalamic Neurons by Glucose
Diabetes, January 1, 2004; 53(1): 67 - 73.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
F. R. Papa, C. Zhang, K. Shokat, and P. Walter
Bypassing a Kinase Activity with an ATP-Competitive Drug
Science, November 28, 2003; 302(5650): 1533 - 1537.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
P. O. Westermark and A. Lansner
A Model of Phosphofructokinase and Glycolytic Oscillations in the Pancreatic {beta}-cell
Biophys. J., July 1, 2003; 85(1): 126 - 139.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Li, T. Hansotia, B. Yusta, F. Ris, P. A. Halban, and D. J. Drucker
Glucagon-like Peptide-1 Receptor Signaling Modulates beta Cell Apoptosis
J. Biol. Chem., January 3, 2003; 278(1): 471 - 478.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
F. Schuit, D. Flamez, A. De Vos, and D. Pipeleers
Glucose-Regulated Gene Expression Maintaining the Glucose-Responsive State of {beta}-Cells
Diabetes, December 1, 2002; 51(90003): S326 - 332.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
K. K. PAPAS, C. K. COLTON, J. S. GOUNARIDES, E. S. ROOS, M. A. C. JAREMA, M. J. SHAPIRO, L. L. CHENG, G. W. CLINE, G. I. SHULMAN, H. WU, et al.
NMR Spectroscopy in {beta} Cell Engineering and Islet Transplantation
Ann. N.Y. Acad. Sci., November 1, 2001; 944(1): 96 - 119.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. L.F. Chan, M. Mourtada, and N. G. Morgan
Characterization of a KATP Channel--Independent Pathway Involved in Potentiation of Insulin Secretion by Efaroxan
Diabetes, February 1, 2001; 50(2): 340 - 347.
[Abstract] [Full Text]


Home page
DiabetesHome page
F. C. Schuit, P. Huypens, H. Heimberg, and D. G. Pipeleers
Glucose Sensing in Pancreatic {beta}-Cells: A Model for the Study of Other Glucose-Regulated Cells in Gut, Pancreas, and Hypothalamus
Diabetes, January 1, 2001; 50(1): 1 - 11.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
A. Shiraishi, Y. Yamada, Y. Tsuura, S. Fijimoto, K. Tsukiyama, E. Mukai, Y. Toyoda, I. Miwa, and Y. Seino
A Novel Glucokinase Regulator in Pancreatic beta Cells. PRECURSOR OF PROPIONYL-CoA CARBOXYLASE beta SUBUNIT INTERACTS WITH GLUCOKINASE AND AUGMENTS ITS ACTIVITY
J. Biol. Chem., January 19, 2001; 276(4): 2325 - 2328.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.